Abstract |
Withania somnifera ( Ashwagandha) is used in Indian traditional medicine, Ayurveda, and is believed to have a variety of health-promoting effects. The molecular mechanisms and pathways underlying these effects have not yet been sufficiently explored. In this study, we investigated the effect of Ashwagandha extracts and their major withanolides ( withaferin A and withanone) on muscle cell differentiation using C2C12 myoblasts. We found that withaferin A and withanone and Ashwagandha extracts possessing different ratios of these active ingredients have different effects on the differentiation of C2C12. Withanone and withanone-rich extracts caused stronger differentiation of myoblasts to myotubes, deaggregation of heat- and metal-stress-induced aggregated proteins, and activation of hypoxia and autophagy pathways. Of note, the Parkinson's disease model of Drosophila that possess a neuromuscular disorder showed improvement in their flight and climbing activity, suggesting the potential of Ashwagandha withanolides for the management of muscle repair and activity.
|
Authors | Jia Wang, Huayue Zhang, Ashish Kaul, Kejuan Li, Didik Priyandoko, Sunil C Kaul, Renu Wadhwa |
Journal | Biomolecules
(Biomolecules)
Vol. 11
Issue 10
(10 04 2021)
ISSN: 2218-273X [Electronic] Switzerland |
PMID | 34680087
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Plant Extracts
- Withanolides
- withanone
- withaferin A
- Ashwagandha
|
Topics |
- Animals
- Cell Differentiation
(drug effects)
- Cell Line
- Humans
- Medicine, Ayurvedic
(trends)
- Mice
- Muscle Cells
(drug effects)
- Parkinson Disease
(drug therapy, pathology)
- Plant Extracts
(chemistry, pharmacology)
- Withanolides
(chemistry, pharmacology)
|